Delivery Order SPE2DB25D3306-SPE2DB25FUBWF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in units of 30, with a ceiling value of $8,765.93. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $4,166.96 and an ultimate completion date of August 1, 2025. The contract does not utilize a set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $10,541.99 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is an antiretroviral combination therapy used for HIV treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This delivery order, valued at $12,117.72, represents a firm fixed price contract with no set-aside designation, reflecting a competitively awarded transaction under open procurement standards. The contract is scheduled for ultimate completion on August 8, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,910.52 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets (30-count units) on September 4, 2025, with completion expected by September 5, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s, with a ceiling value of $6,519.84 and an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,675.06 firm fixed-price delivery order for TRIUMEQ 600-50-300 mg tablets (30-unit pack) to be delivered to Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA Troop Support Medical. TRIUMEQ is an antiretroviral combination medication used in HIV...
- The Defense Logistics Agency awarded a $18,696.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 30-count supplies of TRIUMEQ 600-50-300 mg tablets with a ceiling value of $55,079.80 under firm fixed-price terms. The award, which carries an ultimate completion date of August 13, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $33,210.45 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBWFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This delivery order, valued at $7,559.40 with a firm fixed price structure, represents a competitive award with no set-aside designation. The contract is scheduled for ultimate completion on June 3, 2025, with performance based at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. TRIUMEQ is an antiretroviral medication used in HIV treatment, and this order fulfills the federal government's pharmaceutical supply requirements through AmerisourceBergen's established relationship with DLA. The contractor's extensive portfolio of federal contract awards demonstrates its capability to deliver across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, with all reviewed awards indicating competitive procurement through firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 6/2/25 |